Quarterly report pursuant to Section 13 or 15(d)

Interim Consolidated Balance Sheets

v3.2.0.727
Interim Consolidated Balance Sheets - USD ($)
May. 31, 2015
Nov. 30, 2014
CURRENT    
Cash $ 164,726 $ 1,085,006
Restricted cash 2,500,000 0
Accounts Receivable 9,283 7,393
Inventory 91,452 120,246
Deferred financing costs 138,978 170,674
Prepaid expenses and other receivables 31,734 29,557
Total Current Assets 2,936,173 1,412,876
Plant and Equipment 120,593 144,176
TOTAL ASSETS 3,056,766 1,557,052
CURRENT LIABILITIES    
Accounts payable and accrued liabilities 125,434 161,405
Total Current Liabilities 125,434 161,405
Convertible Debentures 1,398,592 1,398,592
Total Liabilities 1,524,026 1,559,997
Capital Stock    
Preferred stock, $0.001 par value, 5,000,000 shares authorized, Nil issued and outstanding (2014 - nil). The provisions in the Articles of Incorporation allow the directors to issue preferred stock with multiple votes per share and dividend rights, which would have priority over any dividends paid with respect to the holders of Company's common stock. 0 0
Common stock, $0.001 par value 100,000,000 shares authorized (2014: 100,000,000), 46,899,285 issued and outstanding (2014: 46,899,285) 46,899 46,899
Additional Paid-In Capital 24,024,631 24,024,631
Subscription for common stock pending allotment 2,500,000 0
Deficiency (25,000,244) (24,042,769)
Accumulated other comprehensive loss (38,546) (31,706)
Total Stockholders' Equity (Deficiency) 1,532,740 (2,945)
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIENCY) $ 3,056,766 $ 1,557,052